Clinical trial and laboratory investigation of a low-dose progestogen-only contraceptive--Exluton
Foley, M.; Law, B.; Davies, J.; Fotherby, K.
International Journal of Fertility 18(4): 246-251
1973
ISSN/ISBN: 0020-725X PMID: 4359694 Document Number: 493156
Document emailed within 1 workday
Related Documents
Bobtchev, T. 1975: Study of the contraceptive action of a low dose oral progestagen (Exluton) Bruxelles Medical 55(6): 337-342McBride, W.G. 1967: A clinical trial of a new low dose oral contraceptive compound Australian and New Zealand Journal of Obstetrics and Gynaecology 7(4): 222-223
Kaunitz, A.M.; Portman, D.; Westhoff, C.L.; Archer, D.F.; Mishell, D.R.; Foegh, M. 2015: Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill Contraception 91(3): 204-210
Gemzell-Danielsson, K.; van Heusden, A.M.; Killick, S.R.; Croxatto, H.B.; Bouchard, P.; Cameron, S.; Bygdeman, M. 2002: Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen Human Reproduction 17(10): 2588-2593
Gemzell-Danielsson, K.; van Heusden, A.M.; Killick, S.R.; Croxatto, H.B.; Bouchard, P.; Cameron, S.; Bygdeman, M. 2002: Improving cycle control in progestogen-only contraceptive pill users by intermittent treatment with a new anti-progestogen Human Reproduction 17(10): 2588-2593
Sartoretto, J.N.; Ortega-Recio, J.C.; Moraes, R.; Filho, F.N. 1977: Clinical studies with a low dose estrogen-progestogen combination Contraception 15(5): 563-570
Shaaban, O.M.; Ali, M.K.; Sabra, A.M.A.; Abd El Aal, D.E.M. 2015: Levonorgestrel-releasing intrauterine system versus a low-dose combined oral contraceptive for treatment of adenomyotic uteri: a randomized clinical trial Contraception 92(4): 301-307
Brummitt, L.C.; Cunliffe, W.J. 1984: A dose-response investigation of a benzoyl peroxide wash in the treatment of acne--a laboratory study British Journal of Clinical Practice 38(4): 139-140
Tijssen, J.G. 1998: Low-dose and high-dose acetylsalicylic acid, with and without dipyridamole: a review of clinical trial results Neurology 51(3 Suppl 3): S15-S16
Nelson, A.; Apter, D.; Hauck, B.; Schmelter, T.; Rybowski, S.; Rosen, K.; Gemzell-Danielsson, K. 2013: Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial Obstetrics and Gynecology 122(6): 1205-1213
Nelson, A.; Apter, D.; Hauck, B.; Schmelter, T.; Rybowski, S.; Rosen, K.; Gemzell-Danielsson, K. 2013: Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial Obstetrics and Gynecology 122(6): 1205-1213
Bahamondes, L. 2014: Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial Reference 123(3): 667
Morotti, M.; Remorgida, V.; Venturini, P.L.; Ferrero, S. 2014: Progestogen-only contraceptive pill compared with combined oral contraceptive in the treatment of pain symptoms caused by endometriosis in patients with migraine without aura European Journal of Obstetrics Gynecology and Reproductive Biology 179: 63-68
Kato, Y.; Saito, A.; Ishikawa, K.; Nakayama, I.; Tomizawa, M. 1974: Laboratory and clinical investigation of amikacin (BB-K8) Japanese Journal of Antibiotics 27(3): 343-347
Sivin, I.; Mishell, D.R.; Alvarez, F.; Brache, V.; Elomaa, K.; Lähteenmäki, P.; Massai, R.; Miranda, P.; Croxatto, H.; Dean, C.; Small, M.; Nash, H.; Jackanicz, T.M. 2005: Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial Contraception 71(2): 122-129
Kwiecien, M.; Edelman, A.; Nichols, M.D.; Jensen, J.T. 2003: Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: A randomized trial Contraception 67(1): 9-13
Harada, T.; Momoeda, M.; Terakawa, N.; Taketani, Y.; Hoshiai, H. 2011: Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial Fertility and Sterility 95(6): 1928-1931
Kwiecien, M.; Edelman, A.; Nichols, M.D.; Jensen, J.T. 2003: Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: A randomized trial Contraception 67(1): 9-13
Tiedeken, M.; Westhoff, C.L.; Cohen, A.; Cremers, S.; Sitruk-Ware, R.; Blithe, D.L. 2019: Bone turnover markers in women participating in a dose-finding trial of a contraceptive vaginal ring releasing Nestorone and estradiol Contraception 99(6): 329-334
Brown, A.; Cheng, L.; Lin, S.; Baird, D.T. 2002: Daily low-dose mifepristone has contraceptive potential by suppressing ovulation and menstruation: a double-blind randomized control trial of 2 and 5 mg per day for 120 days Journal of Clinical Endocrinology and Metabolism 87(1): 63-70